Genome Profiling
Newark · Founded 2014
About Genome Profiling
Genome Profiling, LLC (www.genprollc.com) is at the forefront of this rapidly emerging market with the first epigenetic biomarker discovery platform that combines a proprietary pre-NGS gDNA preparation kit matched to powerful NGS data analytics algorithms that plug-n-play into standard NGS workflows and enable one NGS run to deliver data for both genomic variant call analyses data AND epigenetic data.
Company Facts
- Founded: 2014
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.1M
- Last round: Convertible Note (Jul 2020)
- Website: https://genomeprofiling.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Clinical Trials, Medical
Canonical: https://fsome.com/organization/genome-profiling-200620 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.